Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac MRI Fibrotic Index in Diabetic Cardiomyopathy
NCT01794091Phase 4Withdrawn
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2013
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in diabetic cardiomyopathy (DCM), sponsored by Brigham and Women's Hospital. Planned start Aug 2013; status: withdrawn.
02
Drugs
eplerenone
03
Conditions
diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01794091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794091.